JPRN-UMIN000027096已完成未知
se experience of tolvaptan for end stage liver disease waiting for liver transplantation. - Use experience of tolvaptan for end stage liver disease waiting for liver transplantation.
The University of Tokyo Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine0 个研究点目标入组 10 人开始时间: 2017年4月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.poor oral intake 2.past history to administrate tolvaptan 3.rejection by patients
研究者
相似试验
招募中
不适用
Safety and efficacy study of four weeks oral administration of tolvaptan in liver cirrhotic patients with hyponatremia and ascitesDiseases of the digestive systemKCT0000569Konkuk University Medical Center104
已完成
不适用
Effect of tolvaptan in decompensated liver cirrhosis patientsJPRN-UMIN000016188shonan kamakura general hospital50
招募中
不适用
Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventionalJPRN-UMIN000008712Division of Kidney and Hypertension, the Jikei University School of Medicine40
招募中
4 期
Efficacy and safety of tolvaptan in Acute Heart FailureCTRI/2013/05/003643SRM Medical College Hospital Research Centre50
已完成
不适用
Study of the safety and efficacy of tolvaptan for fluid retention symptoms of right heart failure due to pulmonary hypertensiopulmonary hypertensionJPRN-UMIN000010196Department of Cardiology, Keio University School of Medicine40